Latest Headlines

  1. ACS Webinar Focuses On Innovative Computational Methods In Drug Discovery
    3/12/2010
    News media and others interested in the chemical sciences are invited to join the next in a series of American Chemical Society (ACS) Webinars, focusing on Professional Growth and Development.
  2. Cellzome Announces Second Major Strategic Drug Discovery Alliance With GlaxoSmithKline In Inflammatory Disease
    3/11/2010
    Cellzome today announced that it has formed a second strategic alliance with GlaxoSmithKline (GSK). This new collaboration gives GSK exclusive access to Cellzome's proprietary Episphere™ technology in the emerging field of epigenetics as applied to immunoinflammatory disease.
  3. Cellular Dynamics And Roche Conduct 'Stem Cells In Drug Discovery And Development' Workshop At The Society Of Toxicology Annual Meeting
    3/4/2010
    Cellular Dynamics International (CDI) and Hoffmann-La Roche Inc. (Roche) today announced a workshop to be held during the Society of Toxicology Annual Meeting in Salt Lake City, UT, on March 7 - 11
  4. Proteomic Technologies Play Crucial Role In Drug Discovery/Molecular Diagnostics In Post-Genomic Era
    3/4/2010
    The Infoshop by Global Information would like to present a new market research report, "Proteomics - Technologies, Markets and Companies" by Jain Pharmabiotech
  5. Optibrium Showcases StarVue At ACS Spring 2010
    3/4/2010
    Optibrium, a provider of software solutions for drug discovery, will be showcasing StarVue on booth #121 at 2010 Spring ACS National Meeting and Exposition, March 21-25, San Francisco, CA, USA. Optibrium's StarVue is a free desktop application that enables scientists to quickly and conveniently view compound structures and data
  6. Zenith Biotech Introducing Novel StemQ Hepatic And Neural Models For Use In Drug Discovery, Metabolism And Toxicology Studies, At The 49th Annual Meeting And ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136
    3/3/2010
    Zenith Biotech is a global life sciences company dedicated to providing high quality stem cells, media, reagents and stem cell-based model systems for a wide variety of cell types and applications. The StemQ product line includes stem cells, media, matrix and reagents tested and qualified for a wide variety of cell types and applications
  7. Corning Incorporated Introduces New Synthemax Synthetic Surface To Enhance And Support Stem Cell Growth
    3/3/2010
    Corning Incorporated recently introduced the Corning Synthemax surface, a novel synthetic surface that supports the growth and differentiation of stem cells. The surface is being commercialized as a result of Corning's ongoing collaboration with Geron Corporation
  8. BIOCIUS Life Sciences Extends Global Presence With Distribution Agreement For Japan
    3/3/2010
    BIOCIUS Life Sciences Inc., developers of the RapidFire high-throughput mass spectrometry system, recently announced an exclusive distribution agreement for the Japanese market with Wako Pure Chemical Industries, Ltd
  9. Mount Sinai School Of Medicine And Medisyn Technologies Discover Novel Compounds For Alzheimer’s Treatment
    3/3/2010
    In an announcement recently, Mount Sinai School of Medicine (MSSM) and Medisyn Technologies, Inc. said they have identified new chemical classes of preclinical compounds that may eventually lead to the first effective management of toxic amyloid aggregation and accumulation in the brain— an abnormal biological process long suspected by many researchers to be a major culprit in the onset and progression of Alzheimer's disease
  10. AB SCIEX Software Application Advances Disease Research, Drug Discovery And Biomarker Research
    3/2/2010
    AB SCIEX, a global leader in life science analytical technologies, recently announced the launch of the first mass-spectrometry-based software application specifically designed to advance the study of lipidomics

First 1 2 3 4 5 6 7 8 9 10 10 (Last)